Cargando…

Inhibition of NFκB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation

Cystic Fibrosis (CF) is one of the most common autosomal genetic disorders in humans. This disease is caused by mutations within a single gene, coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The phenotypic hallmark of CF is chronic lung infection and associated in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maitra, Rangan, Porter, Melissa A, Huang, Shan, Gilmour, Brian P
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689213/ https://www.ncbi.nlm.nih.gov/pubmed/19439083 http://dx.doi.org/10.1186/1476-9255-6-15

Ejemplares similares

Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation
por: Bannon, Aidan, et al.
Publicado: (2015)

Defective CFTR- β-catenin interaction promotes NF-κB nuclear translocation and intestinal inflammation in cystic fibrosis
por: Liu, Kaisheng, et al.
Publicado: (2016)

Inflammation in Cystic Fibrosis
Publicado: (1996)

Tackling Chronic Inflammation with Withanolide Phytochemicals—A Withaferin A Perspective
por: Logie, Emilie, et al.
Publicado: (2020)

Withaferin-A—A Natural Anticancer Agent with Pleitropic Mechanisms of Action
por: Lee, In-Chul, et al.
Publicado: (2016)

Withaferin A protects against spinal cord injury by inhibiting apoptosis and inflammation in mice
por: Yan, Xianlei, et al.
Publicado: (2017)

Withaferin A Inhibits Helicobacter pylori-induced Production of IL-1β in Dendritic Cells by Regulating NF-κB and NLRP3 Inflammasome Activation
por: Kim, Jae-Eun, et al.
Publicado: (2015)

Natural products triptolide, celastrol, and withaferin A inhibit the chaperone activity of peroxiredoxin I
por: Zhao, Qian, et al.
Publicado: (2015)

Human Cellular Models for the Investigation of Lung Inflammation and Mucus Production in Cystic Fibrosis
por: Castellani, Stefano, et al.
Publicado: (2018)

Sodium butyrate inhibits high glucose-induced inflammation by controlling the acetylation of NF-κB p65 in human monocytes
por: Moon, Ha-Rin, et al.
Publicado: (2023)

Withaferin A Effectively Targets Soluble Vimentin in the Glaucoma Filtration Surgical Model of Fibrosis
por: Bargagna-Mohan, Paola, et al.
Publicado: (2013)

Vimentin Phosphorylation Underlies Myofibroblast Sensitivity to Withaferin A In Vitro and during Corneal Fibrosis
por: Bargagna-Mohan, Paola, et al.
Publicado: (2015)

A regulatory SNP modifies cystic fibrosis by disrupting NFκB complex binding on FAS
por: Awah, Chidiebere U, et al.
Publicado: (2015)

Is cellular senescence involved in cystic fibrosis?
por: Bezzerri, Valentino, et al.
Publicado: (2019)

Withaferin-A Reduces Type I Collagen Expression In Vitro and Inhibits Development of Myocardial Fibrosis In Vivo
por: Challa, Azariyas A., et al.
Publicado: (2012)

Implications of Withaferin A in neurological disorders
por: Ram, Natasha, et al.
Publicado: (2020)

Withaferin A Inhibits Nuclear Factor-κB-Dependent Pro-Inflammatory and Stress Response Pathways in the Astrocytes
por: Martorana, Francesca, et al.
Publicado: (2015)

Sphingobacterium respiratory tract infection in patients with cystic fibrosis
por: Lambiase, Antonietta, et al.
Publicado: (2009)

Developing a handheld record for patients with cystic fibrosis
por: Narayan, Omendra, et al.
Publicado: (2015)

The metabolic footprint of the airway bacterial community in cystic fibrosis
por: Narayanamurthy, Vaishnavi, et al.
Publicado: (2017)

Communicating cystic fibrosis newborn screening results to parents
por: Seddon, L., et al.
Publicado: (2020)

Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera’s key metabolite withaferin A
por: Grover, Abhinav, et al.
Publicado: (2010)

Hypoxia Induces Pro-Fibrotic and Fibrosis Marker Genes in Hepatocellular Carcinoma Cells Independently of Inflammatory Stimulation and the NF-κΒ Pathway
por: Triantafyllou, Eleni-Anastasia, et al.
Publicado: (2019)

Infection, inflammation and exercise in cystic fibrosis
por: van de Weert-van Leeuwen, Pauline Barbera, et al.
Publicado: (2013)

Biomarkers of inflammation in infants with cystic fibrosis
por: Laguna, Theresa A., et al.
Publicado: (2018)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Fungal Infection and Inflammation in Cystic Fibrosis
por: Poore, T. Spencer, et al.
Publicado: (2021)

Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran
por: Farjadian, Shirin, et al.
Publicado: (2013)

The impact of telehealth based care on paediatric cystic fibrosis outcomes
por: Rimbaldo, Kristene, et al.
Publicado: (2023)

A refresh of the top 10 research priorities in cystic fibrosis
por: Rowbotham, Nicola Jane, et al.
Publicado: (2023)

NF-κB signaling in inflammation
por: Liu, Ting, et al.
Publicado: (2017)

Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo
por: Yang, Huanjie, et al.
Publicado: (2012)

Withaferin A inhibits ferroptosis and protects against intracerebral hemorrhage
por: Zhou, Zi-Xian, et al.
Publicado: (2022)

Trends in nontuberculous mycobacteria infection in children and young people with cystic fibrosis
por: Abidin, Noreen Zainal, et al.
Publicado: (2021)

Antiproteases as Therapeutics to Target Inflammation in Cystic Fibrosis
por: Quinn, Derek J, et al.
Publicado: (2010)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?
por: Murphy, Sean V., et al.
Publicado: (2019)

Inflammation and Infection in Cystic Fibrosis: Update for the Clinician
por: Petrocheilou, Argyri, et al.
Publicado: (2022)

Involvement of REL/NF-B Transcription Factors in Cellular Senescence
por: Bernard, David, et al.
Publicado: (2001)

An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines
por: Bale, Swarna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3olse6b86m2emsg2h77aopt9i3